Mycosis fungoides: The addition of concurrent and adjuvant interferon to total skin electron beam therapy

British Journal of Dermatology

Volumn 169, Issue 3, 2013, Pages 715-718

  Wagner, A E ^a   Wada, D ^a   Bowen, G ^a   Gaffney, D K ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT ALPHA2B INTERFERON;

ADULT; AGED; CANCER ADJUVANT THERAPY; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LETTER; MALE; MYCOSIS FUNGOIDES; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE FRACTIONATION; RETROSPECTIVE STUDY; TOTAL SKIN ELECTRON THERAPY; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INTERFERONS; MALE; MIDDLE AGED; MYCOSIS FUNGOIDES; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 84883369601     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12386     Document Type: Letter

References (10)

1. Kim YH, Jensen RA, Watanabe GL, et al,. Clinical stage IA (limited patch and plaque) mycosis fungoides. A long-term outcome analysis. Arch Dermatol 1996; 132: 1309-13.
2. Kim YH, Hoppe RT,. Mycosis fungoides and the Sézary syndrome. Semin Oncol 1999; 26: 276-89.
3. Agar NS, Wedgeworth E, Crichton S, et al,. Survival outcomes and prognostic factors in mycosis fungoides/Sézary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal. J Clin Oncol 2010; 28: 4730-9.
4. Quirõs PA, Jones GW, Kacinski BM, et al,. Total skin electron beam therapy followed by adjuvant psoralen/ultraviolet-A light in the management of patients with T1 and T2 cutaneous T-cell lymphoma (mycosis fungoides). Int J Radiat Oncol Biol Phys 1997; 38: 1027-35.
5. Kaye FJ, Bunn PA Jr, Steinberg SM, et al,. A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides. N Engl J Med 1989; 321: 1784-90.
6. Page V, Gardner A, Karzmark CJ,. Patient dosimetry in the electron treatment of large superficial lesions. Radiology 1970; 94: 635-41.
7. Rampino M, Ragona R, Monetti U, et al,. Total skin electron beam therapy in mycosis fungoides. Our experience from 1985 to 1999. Radiol Med 2002; 103: 108-14.
8. Duvic M, Apisarnthanarax N, Cohen DS, et al,. Analysis of long-term outcomes of combined modality therapy for cutaneous T-cell lymphoma. J Am Acad Dermatol 2003; 49: 35-49.
9. Reddy S, Parker CM, Shidnia H, et al,. Total skin electron beam radiation therapy for mycosis fungoides. Am J Clin Oncol 1992; 15: 119-24.
10. Roberge D, Muanza T, Blake G, et al,. Does adjuvant alpha-interferon improve outcome when combined with total skin irradiation for mycosis fungoides? Br J Dermatol 2007; 156: 57-61.